offline
Healthcare | Biotechnology | USA
Regeneron (REGN) Q4 Earnings and Revenues Surpass Estimates
Regeneron (REGN) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $5.69 per share. This compares to earnings of $5.23 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 20.21%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $5.21 per share when it actually produced earnings of $5.87, delivering a surprise of 12.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
...
https://finance.yahoo.com/news/regeneron...12807.html
![[Bild: REGNc1dl1556.png]](https://finviz.com/publish/020619/REGNc1dl1556.png)
Regeneron (REGN) Q4 Earnings and Revenues Surpass Estimates
Regeneron (REGN) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $5.69 per share. This compares to earnings of $5.23 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 20.21%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $5.21 per share when it actually produced earnings of $5.87, delivering a surprise of 12.67%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
...
https://finance.yahoo.com/news/regeneron...12807.html
